NEW YORK (GenomeWeb News) — Genetic Technologies has licensed certain of its non-coding DNA patents to Biosearch Technologies for research purposes, GTG said today.
 
BTI will use the worldwide license, which includes IP for SNP genotyping and allelic discrimination, to manufacture and distribute oligos, probes, and primers for research use only.
 
All of BTI’s customers will be covered under the GTG patents, GTG said.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.